EP2648808B1 - Compositions comprenant des composés d'ammonium quaternaire - Google Patents
Compositions comprenant des composés d'ammonium quaternaire Download PDFInfo
- Publication number
- EP2648808B1 EP2648808B1 EP11807639.7A EP11807639A EP2648808B1 EP 2648808 B1 EP2648808 B1 EP 2648808B1 EP 11807639 A EP11807639 A EP 11807639A EP 2648808 B1 EP2648808 B1 EP 2648808B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- weight
- composition
- group
- compositions
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 86
- 150000003856 quaternary ammonium compounds Chemical class 0.000 title claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 52
- 150000002191 fatty alcohols Chemical class 0.000 claims description 24
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 18
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 18
- 125000004432 carbon atom Chemical group C* 0.000 claims description 16
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 14
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims description 14
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 claims description 14
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 9
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 9
- 239000000194 fatty acid Substances 0.000 claims description 9
- 229930195729 fatty acid Natural products 0.000 claims description 9
- 150000004665 fatty acids Chemical class 0.000 claims description 9
- 229960000541 cetyl alcohol Drugs 0.000 claims description 8
- 239000008188 pellet Substances 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 150000001450 anions Chemical class 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 4
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 claims description 4
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 claims description 4
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 3
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 2
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical group O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 claims description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 2
- PUAQLLVFLMYYJJ-UHFFFAOYSA-N 2-aminopropiophenone Chemical compound CC(N)C(=O)C1=CC=CC=C1 PUAQLLVFLMYYJJ-UHFFFAOYSA-N 0.000 description 15
- 235000011187 glycerol Nutrition 0.000 description 15
- 239000002904 solvent Substances 0.000 description 12
- 238000009472 formulation Methods 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- -1 alkyl glycols Chemical class 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 125000002091 cationic group Chemical group 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000470 constituent Substances 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 235000010603 pastilles Nutrition 0.000 description 6
- 150000002334 glycols Chemical class 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- QHZLMUACJMDIAE-UHFFFAOYSA-N 1-monopalmitoylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)CO QHZLMUACJMDIAE-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 229940075506 behentrimonium chloride Drugs 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- BTFJIXJJCSYFAL-UHFFFAOYSA-N icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000012736 aqueous medium Substances 0.000 description 3
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 229940127557 pharmaceutical product Drugs 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- YWWVWXASSLXJHU-AATRIKPKSA-N (9E)-tetradecenoic acid Chemical compound CCCC\C=C\CCCCCCCC(O)=O YWWVWXASSLXJHU-AATRIKPKSA-N 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 240000002989 Euphorbia neriifolia Species 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- ARIWANIATODDMH-UHFFFAOYSA-N Lauric acid monoglyceride Natural products CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229940081733 cetearyl alcohol Drugs 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 239000005968 1-Decanol Substances 0.000 description 1
- UMEKPPOFCOUEDT-UHFFFAOYSA-N 1-icosanoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO UMEKPPOFCOUEDT-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- YWWVWXASSLXJHU-UHFFFAOYSA-N 9E-tetradecenoic acid Natural products CCCCC=CCCCCCCCC(O)=O YWWVWXASSLXJHU-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 229940124091 Keratolytic Drugs 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- ALSTYHKOOCGGFT-UHFFFAOYSA-N cis-oleyl alcohol Natural products CCCCCCCCC=CCCCCCCCCO ALSTYHKOOCGGFT-UHFFFAOYSA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 239000007957 coemulsifier Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 230000005226 mechanical processes and functions Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- NNNVXFKZMRGJPM-KHPPLWFESA-N sapienic acid Chemical compound CCCCCCCCC\C=C/CCCCC(O)=O NNNVXFKZMRGJPM-KHPPLWFESA-N 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 229940100458 steareth-21 Drugs 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0254—Platelets; Flakes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
Definitions
- the invention relates to the fields of chemistry and personal care products and provides additives which are useful and convenient for formulating shampoos, conditioners.
- Fatty quaternary ammonium compositions are useful additives to hair care products such as shampoos, conditioners.
- quats are useful additives to hair care products such as shampoos, conditioners.
- U.S. Patent No. 4,891,214 issuing to Stevens et al. on January 2nd, 1999 provides an informative background into quats and their uses.
- the above mentioned requirements can be achieved by adding short-chain alcohols, in particular isopropanol or ethanol, in amounts of from 15 to 20% by weight.
- the short-chain alcohols are volatile organic solvents which raise significant environmental and safety concerns, not only for the manufacturer but also both for the consumer and for the company formulating the personal care products. Therefore, it is desirable to find other, non-volatile solvent/formulation systems.
- compositions containing quats and fatty alcohols do not share the same problem with volatility and can be flakeable.
- fatty alcohols such as cetearyl alcohol have been used as quat solvents.
- these compositions have a quat content of less than 35%.
- Attempts to increase the cationic activity, namely the amount of quat used, up to 35% leads to products with melting points typically over 100°C and in order to effectively handle and, ultimately, flake the material, it must often be heated to a point near, or above this temperature, in which the quat can begin to degrade.
- this relatively high content of fatty alcohol tends to dramatically increase the viscosity of the finished product.
- the short-chain alcohols can be replaced by linear fatty alcohols, e. g. cetyl alcohol, lauryl alcohol, behenyl alcohol, or stearyl alcohol and alkyl glycols, such as for example, propylene glycol or 1,3-butandiol, which are additionally added in order to lower the setting point or melting point of the mixtures to temperatures below 100 °C.
- linear fatty alcohols e. g. cetyl alcohol, lauryl alcohol, behenyl alcohol, or stearyl alcohol and alkyl glycols, such as for example, propylene glycol or 1,3-butandiol, which are additionally added in order to lower the setting point or melting point of the mixtures to temperatures below 100 °C.
- alkyl glycols mentioned in WO 00/28950 A1 could be also used alone as solvent systems for quats. However, they have a number of drawbacks. First, quats containing glycols as a solvent generally result in formulations which are not flakable. Instead, they form a so what viscous, waxy "gummy" solid. While this material may have a lower overall melting point than the fatty alcohol based solvent quats, the overall handling problems involved from this material are significantly greater.
- glycols are typically coming from synthetic sources.
- Today's personal care market is challenged to find innovative, natural alternatives to synthetic and petroleum-based chemicals that have similar or better performance.
- EP 1 269 992 B1 discloses compositions comprising quaternary ammonium compounds and at least one polyhydric alcohol having 5 to 12 carbon atoms. According to the teaching of this document, these compositions shall have low setting and melting points, good dispersability in aqueous media and have a low flashpoint. According to a preferred embodiment these compositions are free from fatty alcohols and linear or branched monoalcohols having 8 to 36 carbon atoms.
- the compositions disclosed in EP 1 269 992 B1 shall have low setting points and being nevertheless sufficiently hard and brittle at room temperature to allow pelleting or flaking, what solves the first drawback of the use of glycols as a sole solvent system. However, these polyhydric alcohols are also typically coming from synthetic sources.
- each attempt to increase the quat content in the compositions while obtaining the desirable commercial handling properties of quats falls short in one aspect or another.
- Use of water as a solvent generally results in compositions with a comparatively low quat-content.
- Use of short-alkyl alcohols as a solvent is problematical due to their high organic volatility.
- Glycols, whether used alone or in combination with fatty alcohols, are generally petrochemical derivatives and unpopular in personal care applications.
- the use of solvent systems comprising long chain alkyl fatty alcohols what leads to products with better environmental profile, results in low cationic activity of the quats and requires heating the resulting product to a point in which the quats begin to degrade.
- compositions comprising quaternary ammonium compounds, at least one glycerol monoester of a C 12-24 fatty acid and fatty alcohols generally result in formulations which have low setting and melting points, good dispersability in aqueous media by maintaining the cationic activity of the quat, wherein the amount of the quat in the composition is particularly preferably higher than 40% and more preferably at least 50% by weight.
- the concentrated compositions of the present invention can be free from short chain alcohols, in particular isopropanol and glycols such as for example propylene glycol or 1,3-butandiol.
- the novel compositions are thus formulated with only solvents based from renewable resources, achieve a high active matter of about 50% by weight and are thus highly suitable for formulating quaternary ammonium compounds for personal care applications.
- compositions comprising, based on the finished composition,
- the relative portions of a) to b) to c) depends somewhat on the quat used and the glycerol monoester and fatty alcohol mixture used.
- the fluidity of the composition of the invention is important from a manufacturing standpoint because without the proper final commercial handling properties, it will be extremely difficult to produce a commercially feasible product. During manufacture, the product has to be stirred, heated, cooled as needed and often transferred in a fluid state to a flaking or a pastillation line. All of this needs to be achieved at commercially viable temperatures, temperatures which will not degrade the quat.
- the proportion of quaternary ammonium compounds (a) based on the finished composition is 40 to 60 % per weight, particularly preferably 45 to 55 % by weight, especially preferably 50 % by weight. Surprisingly it has been found, that the compositions can advantageously have high portions by weight of quaternary ammonium compounds (a) coupled with simultaneously low melting and setting points.
- Quaternary ammonium compounds a) are preferably (C 12 -C 36 )-, preferably (C 14 -C 24 )-, practically preferably (C 16 -C 24 )-alkyltrimethylamonium compounds. Particular preference is given to alkyltrimethylammonium compounds in which the alkyl radical is a behenyl, erucyl, cetyl or stearyl radical.
- the anion X- in Formula (1) maybe any desired charge-balancing anion; according to the invention, the anion is an anion selected from the group consisting of chloride, iodide, bromide, methosulfate, hydrogensulfate, lactate, citrate, carbonate and bicarbonate or a mixture thereof.
- a very particularly suitable quaternary ammonium compound a) is behenyltrimethylammonium chloride.
- the proportion of glycerol monoesters or the proportion of the glycerol monoester b) is, based on the finished compositions, 15 to 25 % by weight, particularly preferably 17 to 23 % by weight, especially preferably 20% by weight.
- Glycerol monoesters selected from the group consisting of glycerol monoester of one or more C 12-24 fatty acid(s), b), are to be understood as meaning fatty acid monoesters with glycerol, wherein the fatty acid is a saturated or unsaturated fatty acid.
- the fatty acid is selected from the group consisting of lauric acid, myristic acid, palmitic acid, stearic acid, arachidic acid, myristoleic acid, palmitoleic acid, sapienic acid, oleic acid and arichidonic acid.
- glycerol monoesters can include glycerol monostearate, glycerol monopalmitate, glycerol arachidate, glycerol oleate, glycerol laurate and mixtures thereof.
- the glycerol monoester, constituent b) of the composition of the invention is selected from the group consisting of glycerol monostearate and/or glycerol monopalmitate.
- constituent b) is glycerol monostearate wherein the fatty acid is a mixture 50:50 % by weight of palmitic acid and stearic acid.
- the proportion of fatty alcohols having 10 to 20 carbon atoms, constituent c) of the composition of the invention is, based on the finished compositions, 25 to 35 % by weight, particularly preferably 27 to 33 % by weight, especially preferably 30 % by weight.
- Constituent c) is characterized in that it comprises:
- constituent (ca) to constituent (cb) from 1,0 to 1,5, preferably from 1,0 to 1,2, leads to compositions with low setting and melting points, which are fluid enough to be manufactured feasible and flakeable.
- fatty alcohols having 10 to 20 carbon atoms, c) are mixtures selected of a the group consisting of capric alcohol (1-decanol), lauryl alcohol (1-dodecanol), myristyl alcohol (1-tetradecanol), cetyl alcohol (1-hexadecanol), stearyl alcohol (1-octadecanol), oleyl alcohol (cis-9-Octadecen-1-ol) and arachidyl alcohol (1-eicosanol).
- the fatty alcohols, compounds (c) are selected from the group consisting of 1-dodecanol, 1-tetradecanol, 1-hexadecanol and 1-octadecanol.
- the composition consists of 50% by weight of behenyltrimethylammonium chloride, 20% by weight of glyceryl monostearate, 4,5% by weight of 1-hexadecanol, 10,5% by weight of 1-octadecanol, 10,5% by weight of 1-dodecanol, and 4,5% by weight of 1-tetradecanol.
- compositions of the invention preferably have setting points below 100 °C, very particularly preferably below 95 °C.
- compositions according to the invention may for example be in a form selected from the group consisting of pellets, flakes, extrudates, pastes, compacts, emulsions, dispersions, and mixtures thereof. According to a preferred embodiment the compositions are in the form of pellets or flakes. Flakes or pellets are desired in the commercial industry because they are easily handled and incorporated into desired products.
- compositions are free-flowing liquids over their setting points, making them easy to manufacture and easy to transfer and pump through transfer lines to flaking or pastillation equipment when it is chilled below its melting point and either broken into easy to handle flakes or dispensed into pellets/pastilles and cooled.
- the claimed compositions generally require the setting point to be below 100°C in order to facilitate the transfer to the flaking lines while maintaining the integrity of the quats in the composition. More preferably the setting point of the compositions is below 95 °C. Whether a formulation is flakable is measured by pouring a relatively thin film of the heated composition onto a metal sheet and allowing it to cool. The cooled film is then "crumbled” or “scraped” into small flakes by any type of mechanical process.
- a successful composition must possess two properties. First, the composition must possess the property of being easily poured onto the sheet plus forming a thin film. Second, once the composition is allowed to cool, it must brake into flakes after crumbling or scrapping. These flakes are consequently easily stored and re-melted as necessary.
- Pastillation is a process in which small amounts of the desired formulation are dispensed into pastilles/pellets. These pastilles are then allowed to cool, forming a product which is in solid form but easy returned to liquid state. Whether a formulation is escapable of pastillation is measurable by distributing small amounts of the heated formulation into pastilles. These pastilles are then allowed to cool. The pastilles must be easily melted without tremendous amounts of heat, preferably below the boiling point of water.
- compositions of the present invention are generally suitable for the preparation of products / compositions comprising quaternary ammonium compounds.
- compositions are particularly suitable for the preparation of cosmetics, dermatological and pharmaceutical products.
- the invention accordingly also provides for the use of the compositions according to the invention for the preparation of products, preferably cosmetics, dermatological and pharmaceutical compositions in particular hair treatment compositions, comprising quaternary ammonium compounds.
- Examples of preferred products are shampoos, rinse-off hair conditioners, cream rinsers, clear rinsers, hair cures, hair colorants and hair tints, permanent waiving compositions, hair gels, hair conditioners in aerosol, spray and fluid form, two-in-one shower preparations, cream shower preparations, skin care compositions, day creams, night creams, care creams, nutrient creams, body lotions and ointments.
- the cosmetic, dermatological and pharmaceutical products or compositions comprise the compositions according to the invention, based on the finished product preferably in amounts of from 0.1 to 15% by weight, particularly preferably 1 to 10% by weigh.
- the cosmetic, dermatological and pharmaceutical products can comprise as further auxiliaries and additives, all customary surfactants, oily substances, emulsifiers and co-emulsifiers, cationic polymers, film formers, super fatting agents, moisture donating agents, stabilizers, biogenic active ingredients, preservatives, pearlizing agents, dyes and fragrances, solvents, glycerol, hydrotrophic agents, opacifiers, thickeners, dispersions, protein derivatives, such as gelatines, collagen hydrolysates, natural and synthetic-based polypeptides, egg yolk, lecithin, lanolin and lanolin derivatives, silicones, deodorizing agents, substances with a keratolytic and keratoplastic action, enzymes, carrier substances, and antioxidants, UV-Light protection filters, pigments and metal oxides and antimicrobially effective agents.
- all customary surfactants such as gelatines, collagen hydrolysates, natural and synthetic-based polypeptides, egg yolk, lecithin
- a composition of 50% by weight of behenyltrimethylammonium chloride is prepared in a known manner by alkylation of a tertiary amine with methyl chloride in the presence of the following solvent types and ratios: Glyceryl stearate: 20% by weight C 18 alcohol: 10,5% by weight C 16 alcohol: 4,5% by weight C 14 alcohol: 4,5% by weight C 12 alcohol: 10,5% by weight
- Phase Component Percentage (%wt) A Demineralized water Qsp 100% Tetrasodium EDTA 0.05 Citric acid 0.05 B Hydroxyethylcellulose (HEC) 0.75 Glycerin 2 C Steareth-21 1 Quat Qsp 0.5% active matter D Cetyl alcohol 2.5 F Preservative (Microcare ® IT, Thor) 0.075 Fragrance 0.5 Total 100%
- Example 1 The product composition of the Example 1 gives similar results when comparing both wet combing and formula viscosity than a standard Behentrimonium chloride with Isopropanol.
- Example Active* (%) Glyceryl Stearate C 18 alcohol [% by wt] C 16 alcohol [% by wt] C 14 alcohol [% by wt] C 12 alcohol [% by wt] Comments 2 50 50 0 0 0 0 NPF 3 50 0 35 15 0 0 NPF 4 50 0 0 0 15 35 v: 5570 cp 5 50 0 21 9 6 14 NPF 6 50 20 21 9 0 0 NPF 7 50 20 0 0 9 21 v: 8320 cp 8 50 30 7 3 3 7 NPF 9 34 0 33 33 0 0 v: 17580 * Active: Behentrimonium chloride [% by weight] NPF: not production feasible (setting points higher than 100°C) v: Viscosity of the final formula (20°C after 1 week, RvM4V10 1')
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Claims (8)
- Composition comprenant, sur la base de la composition finie,a) de 40 à 60% en poids d'au moins un composé quaternaire selon la formule (1)
R2, R3 et R4 sont indépendamment les uns des autres, peuvent être identiques et sont un groupement -CH3, CH3CH2-, CH3CH2CH2-, CH3CH2CH2CH2-, -CH2CH2OH ou -CH2CH(OH)CH2OH, et X- est un anion choisi dans le groupe constitué par le chlorure, l'iodure, le bromure, le méthosulfate, l'hydrogénosulfate, le lactate, le citrate, le carbonate et le bicarbonate, ou des mélanges de ceux-ci, etb) de 15 à 25% en poids d'au moins un monoester de glycérol choisi dans le groupe constitué par un monoester de glycérol d'un acide gras en C12-24, etc) de 25 à 35% en poids d'un mélange d'alcools gras ayant de 10 à 20 atomes de carbone,caractérisé en ce que ledit mélange d'alcools gras comprend :(ca) au moins un alcool gras ayant de 10 à 14 atomes de carbone, et(cb) au moins un alcool gras ayant de 16 à 20 atomes de carbone,où le rapport pondéral de (ca) à (cb) va de 1,0 à 1,5. - Composition selon la revendication 1, dans laquelle les composés d'ammonium quaternaire, les composés a), sont des composés de (C12-C36)-, préférablement de (C14-C24)-, particulièrement préférablement de (C16-C24)-alkyltriméthylammonium.
- Composition selon la revendication 1 ou 2, dans laquelle le composé d'ammonium quaternaire, le composé a), est le chlorure de béhényltriméthylammonium.
- Composition selon les revendications 1 à 3, dans laquelle le au moins un monoester de glycérol, le composé b), est le monostéarate de glycérol.
- Composition selon les revendications 1 à 4, dans laquelle les alcools gras, les composés c), sont choisis dans le groupe constitué par le 1-dodécanol, le 1-tétradécanol, le 1-hexadécanol et le 1-octadécanol.
- Composition selon les revendications 1 à 5, dans laquelle la composition est constituée de 50% en poids de chlorure de béhényltriméthylammonium, 20% en poids de monostéarate de glycérol, 4,5% en poids de 1-hexadécanol, 10,5% en poids de 1-octadécanol, 10,5% en poids de 1-dodécanol, et 4,5% en poids de 1-tétradécanol.
- Composition selon les revendications 1 à 6, qui se trouve sous la forme de pastilles ou de paillettes.
- Composition selon les revendications 1 à 7, ayant un poids de solidification inférieur à 95°C.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11807639.7A EP2648808B1 (fr) | 2010-12-10 | 2011-12-08 | Compositions comprenant des composés d'ammonium quaternaire |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10015509 | 2010-12-10 | ||
EP11807639.7A EP2648808B1 (fr) | 2010-12-10 | 2011-12-08 | Compositions comprenant des composés d'ammonium quaternaire |
PCT/EP2011/006186 WO2012076177A2 (fr) | 2010-12-10 | 2011-12-08 | Compositions comprenant des composés d'ammonium quaternaire |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2648808A2 EP2648808A2 (fr) | 2013-10-16 |
EP2648808B1 true EP2648808B1 (fr) | 2015-03-18 |
Family
ID=45470503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP11807639.7A Active EP2648808B1 (fr) | 2010-12-10 | 2011-12-08 | Compositions comprenant des composés d'ammonium quaternaire |
Country Status (4)
Country | Link |
---|---|
US (1) | US20130251655A1 (fr) |
EP (1) | EP2648808B1 (fr) |
ES (1) | ES2538651T3 (fr) |
WO (1) | WO2012076177A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102012223197A1 (de) | 2012-12-14 | 2014-06-18 | Henkel Ag & Co. Kgaa | Wasserfreie Zusammensetzungen gegen Körpergeruch |
SG11202013227UA (en) * | 2018-07-12 | 2021-01-28 | Stepan Co | Esterquat compositions |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3689478T2 (de) * | 1986-10-23 | 1994-07-21 | Witco Corp | Teilchenförmiges emulgierbares haarkonditioniermittel. |
US4886660A (en) * | 1987-06-11 | 1989-12-12 | Colgate-Palmolive Company | Shine hair conditioner |
DE3837860A1 (de) * | 1988-11-08 | 1990-05-10 | Wella Ag | Lagerstabiles haarkonditionierungsmittel mit perlglanz |
US5989533A (en) * | 1997-07-21 | 1999-11-23 | Revlon Consumer Products Corporation | Hair conditioning compositions containing alpha or beta hydroxy acid esters |
WO2000028950A1 (fr) * | 1998-11-12 | 2000-05-25 | Croda, Inc. | Compositions d'ammonium quaternaire gras |
DE10009996B4 (de) * | 2000-03-02 | 2005-10-13 | Cognis Ip Management Gmbh | Feststoffgranulate mit monodisperser Korngrößenverteilung, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung |
DE10126253A1 (de) * | 2001-05-29 | 2002-12-05 | Clariant Gmbh | Neuartig konfektionierte quaternäre Ammoniumverbindungen |
DE10129225A1 (de) * | 2001-06-19 | 2003-01-02 | Clariant Gmbh | Neuartig konfektionierte quaternäre Ammoniumverbindungen |
JP4911877B2 (ja) * | 2002-01-09 | 2012-04-04 | クローダ,インコーポレイテッド | 第四級化合物の混合物 |
JP4589050B2 (ja) * | 2003-12-22 | 2010-12-01 | 日本精化株式会社 | ジエステル及び油剤、並びに化粧料及び皮膚外用剤 |
EP1786521A1 (fr) * | 2004-09-09 | 2007-05-23 | Unilever Plc | Compositon revitalisante capillaire anhydre |
-
2011
- 2011-12-08 ES ES11807639.7T patent/ES2538651T3/es active Active
- 2011-12-08 WO PCT/EP2011/006186 patent/WO2012076177A2/fr active Application Filing
- 2011-12-08 EP EP11807639.7A patent/EP2648808B1/fr active Active
- 2011-12-08 US US13/992,221 patent/US20130251655A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2012076177A3 (fr) | 2013-12-12 |
ES2538651T3 (es) | 2015-06-23 |
EP2648808A2 (fr) | 2013-10-16 |
US20130251655A1 (en) | 2013-09-26 |
WO2012076177A2 (fr) | 2012-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2464012C1 (ru) | Композиция для кондиционирования волос | |
CN1798542B (zh) | 含二酯季铵化合物的个人护理产品 | |
US7074395B2 (en) | Cosmetic formulations of quaternary ammonium compounds incorporating polyhydric alcohols | |
BRPI1100869A2 (pt) | composições compreendendo compostos de amÈnio quaternário e carbonatos orgánicos | |
EP1935878B1 (fr) | Hydroxyalkylurée pour un effet hydradant amélioré | |
US6919074B2 (en) | Cosmetic formulations of quaternary ammonium compounds free of short-chain alcohols | |
JP4370078B2 (ja) | 新規第四アンモニウム化合物組成物 | |
CN114929182B (zh) | 具有含有苯甲酸钠和二醇和/或甘油酯的防腐体系的毛发调理剂组合物 | |
WO2010116941A1 (fr) | Produit cosmetique pour les cheveux | |
EP3532012B1 (fr) | Compositions de soins capillaires comprenant des matières qui modifient le sébum | |
EP2648808B1 (fr) | Compositions comprenant des composés d'ammonium quaternaire | |
JP2004352688A (ja) | 防腐剤組成物 | |
WO1998017254A1 (fr) | Formulations cosmetiques contenant de la gliadine | |
CN111372563A (zh) | 毛发化妆品 | |
JP3649619B2 (ja) | 外用組成物 | |
CN114929183A (zh) | 含有二十二烷酰氨基丙基二甲基胺的毛发调理剂组合物 | |
JPH02172908A (ja) | エアゾール型毛髪化粧料 | |
JP3649620B2 (ja) | 外用組成物 | |
JP2024138105A (ja) | 化粧料 | |
JP2022139147A (ja) | 固形コンディショナー組成物 | |
JPH0655656B2 (ja) | 毛髪化粧料 | |
BRPI0917027B1 (pt) | Hair conditioner composition and method of using such composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20130618 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
R17D | Deferred search report published (corrected) |
Effective date: 20131212 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61Q 5/12 20060101ALI20140916BHEP Ipc: A61Q 5/02 20060101AFI20140916BHEP Ipc: A61K 8/41 20060101ALI20140916BHEP Ipc: A61K 8/34 20060101ALI20140916BHEP Ipc: A61K 8/37 20060101ALI20140916BHEP Ipc: A61K 8/02 20060101ALI20140916BHEP |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
DAX | Request for extension of the european patent (deleted) | ||
INTG | Intention to grant announced |
Effective date: 20141027 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 716155 Country of ref document: AT Kind code of ref document: T Effective date: 20150415 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602011014908 Country of ref document: DE Effective date: 20150507 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2538651 Country of ref document: ES Kind code of ref document: T3 Effective date: 20150623 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20150318 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20150318 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150618 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 716155 Country of ref document: AT Kind code of ref document: T Effective date: 20150318 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150619 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150720 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150718 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 5 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602011014908 Country of ref document: DE |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 |
|
26N | No opposition filed |
Effective date: 20151221 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20151231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 Ref country code: LU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151208 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20151208 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20151231 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20151231 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 6 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20111208 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 7 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150318 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20231220 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20231220 Year of fee payment: 13 Ref country code: DE Payment date: 20231214 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20240118 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20231229 Year of fee payment: 13 |